FdaNdcDirectoryPulse / compare
BRYTLY vs loperamide hydrochloride and simethicone: FdaNdcDirectoryPulse comparison
BRYTLY (2026-10-16) and loperamide hydrochloride and simethicone (2026-09-24) are peer FdaNdcDirectoryPulse records.
Data as of · Compiled by Zalwin from U.S. FDA National Drug Code (NDC) Directory via openFDA
Both records plus every comparable record, with all columns and source links · Card, Apple Pay, Google Pay or Link via Stripe
How does BRYTLY compare to loperamide hydrochloride and simethicone?
| Field | BRYTLY | loperamide hydrochloride and simethicone |
|---|---|---|
| Product | BRYTLY | loperamide hydrochloride and simethicone |
| Generic name | Apraclonidine Hydrochloride | loperamide hydrochloride, simethicone |
| NDC | 0065-8596 | 72288-728 |
| Labeler | Alcon Laboratories, Inc. | Amazon.com Services LLC |
| Product type | HUMAN OTC DRUG | HUMAN OTC DRUG |
| Approval pathway | NDA | ANDA |
| Application number | NDA220341 | ANDA209837 |
| Dosage form | SOLUTION/ DROPS | TABLET |
| Route | OPHTHALMIC | ORAL |
| Active ingredients | APRACLONIDINE HYDROCHLORIDE 1.25 mg/mL | LOPERAMIDE HYDROCHLORIDE 2 mg/1; DIMETHICONE 125 mg/1 |
| Marketing start | 2026-10-16 | 2026-09-24 |
| Package configurations | 3 | 1 |
| Launch Signal Score | 45/100 | 40/100 |
| Peer rank and all 500 records (CSV) | 🔒 Click to unlock → | |
| Official source URLs for every peer record | 🔒 Click to unlock → | |
Official records: BRYTLY · loperamide hydrochloride and simethicone
Get new listings in your categories
FdaNdcDirectoryPulse emails new drug listings matching your pathway and product type.
Listing data comes from the FDA NDC directory via openFDA; a listing is not an FDA approval or endorsement and may be updated or withdrawn. Informational only; not medical advice.